SEC Form 4 · accession 0001140361-15-044132
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Wachter Ph.D.
Officer — Chief Technology Officer
Period of report
Dec 9, 2015
Accepted (ET)
Dec 10, 2015 · 1:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.75 | Dec 9, 2015 | A | 400,000 | A | Dec 9, 2015 | Dec 9, 2025 | Common Stock | 400,000 | 400,000 | D |